Targeting Raf/MEK/ERK pathway in pituitary adenomas

European Journal of Cancer

Volumn 48, Issue 3, 2012, Pages 389-395

  Zhang, Suojun ^a   Wan, Feng ^a   Guo, Dongsheng ^a   Lei, Ting ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Pituitary adenomas; Raf; Signalling pathway

Indexed keywords

ADENYLATE CYCLASE; ANGIOTENSIN II; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIACYLGLYCEROL; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR; GROWTH HORMONE SECRETAGOGUE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; OCTREOTIDE; PASIREOTIDE; PHOSPHOLIPASE C; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN 14 3 3; PROTEIN KINASE C; RAF PROTEIN; SOS PROTEIN;

ANTIPROLIFERATIVE ACTIVITY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HYPOPHYSIS ADENOMA; INHIBITION KINETICS; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR PATHOLOGY; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; REVIEW;

ADENOMA; ANTINEOPLASTIC AGENTS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; PITUITARY NEOPLASMS; RAF KINASES; SIGNAL TRANSDUCTION;

EID: 84856216099     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.11.002     Document Type: Article

References (119)

1. S. Melmed Update in pituitary disease J Clin Endocrinol Metab 93 2008 331 338 (Pubitemid 351240799)
2. A. Beckers, and A.F. Daly The clinical, pathological, and genetic features of familial isolated pituitary adenomas Eur J Endocrinol 157 2007 371 382 (Pubitemid 350018439)
3. S.A. Boikos, and C.A. Stratakis Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis Hum Mol Genet 16 Spec. No. 1 2007 R80 R87
4. A. Horvath, and C.A. Stratakis Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors Rev Endocr Metab Disord 9 2008 1 11
5. C.A. Leontiou, M. Gueorguiev, and J.V. der Spuy The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas J Clin Endocrinol Metab 93 2008 2390 2401 (Pubitemid 351831563)
6. D. Dworakowska, E. Wlodek, and C.A. Leontiou Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors Endocr Relat Cancer 16 2009 1329 1338
7. J.A. McCubrey, L.S. Steelman, and W.H. Chappell Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance Biochim Biophys Acta 1773 2007 1263 1284 (Pubitemid 47125967)
8. P.J. Roberts, and C.J. Der Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Oncogene 26 2007 3291 3310 (Pubitemid 46763022)
9. C. Wellbrock, M. Karasarides, and R. Marais The RAF proteins take centre stage Nat Rev Mol Cell Biol 5 2004 875 885 (Pubitemid 39486539)
10. A. Carracedo, and P.P. Pandolfi The PTEN-PI 3K pathway: of feedbacks and cross-talks Oncogene 27 2008 5527 5541
11. J.A. Aguirre-Ghiso, Y. Estrada, D. Liu, and L. Ossowski ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK) Cancer Res 63 2003 1684 1695 (Pubitemid 36373662)
12. A. Carracedo, L. Ma, and J. Teruya-Feldstein Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer J Clin Invest 118 2008 3065 3074
13. A.S. Dhillon, S. Hagan, O. Rath, and W. Kolch MAP kinase signalling pathways in cancer Oncogene 26 2007 3279 3290 (Pubitemid 46763021)
14. C. Gulmann, K.M. Sheehan, and R.M. Conroy Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer J Pathol 218 2009 514 519
15. E.K. Kim, and E.J. Choi Pathological roles of MAPK signaling pathways in human diseases Biochim Biophys Acta 1802 2010 396 405
16. J.A. McCubrey, M.M. Lahair, and R.A. Franklin Reactive oxygen species-induced activation of the MAP kinase signaling pathways Antioxid Redox Signal 8 2006 1775 1789 (Pubitemid 44726351)
17. S. Torii, T. Yamamoto, Y. Tsuchiya, and E. Nishida ERK MAP kinase in G cell cycle progression and cancer Cancer Sci 97 2006 697 702 (Pubitemid 43983780)
18. E.F. Wagner, and A.R. Nebreda Signal integration by JNK and p38 MAPK pathways in cancer development Nat Rev Cancer 9 2009 537 549
19. A. Zebisch, and J. Troppmair Back to the roots: the remarkable RAF oncogene story Cell Mol Life Sci 63 2006 1314 1330 (Pubitemid 43939015)
20. G. Zhao, H. Zhao, and L. Tu Effects and mechanism of irbesartan on tubulointerstitial fibrosis in 5/6 nephrectomized rats J Huazhong Univ Sci Technol Med Sci 30 2010 48 54
21. J. Liu, L. Liu, Y. Cui, J. Zhang, and H. Jiang p38 MAPK regulates Th2 cytokines release in PBMCs in allergic rhinitis rats J Huazhong Univ Sci Technol Med Sci 30 2010 222 225
22. C.A. Hazzalin, and L.C. Mahadevan MAPK-regulated transcription: a continuously variable gene switch Nat Rev Mol Cell Biol 3 2002 30 40 (Pubitemid 135709916)
23. Y. Liu, E.G. Shepherd, and L.D. Nelin MAPK phosphatases - regulating the immune response Nat Rev Immunol 7 2007 202 212
24. M. Raman, W. Chen, and M.H. Cobb Differential regulation and properties of MAPKs Oncogene 26 2007 3100 3112 (Pubitemid 46763006)
25. H.J. Schaeffer, and M.J. Weber Mitogen-activated protein kinases: specific messages from ubiquitous messengers Mol Cell Biol 19 1999 2435 2444 (Pubitemid 29144487)
26. A.G. Turjanski, J.P. Vaque, and J.S. Gutkind MAP kinases and the control of nuclear events Oncogene 26 2007 3240 3253 (Pubitemid 46763018)
27. M. Cakir, and A.B. Grossman Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis Expert Opin Ther Targets 13 2009 1121 1134
28. F. Chang, L.S. Steelman, and J.T. Lee Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention Leukemia 17 2003 1263 1293 (Pubitemid 36857335)
29. T.S. Lewis, P.S. Shapiro, and N.G. Ahn Signal transduction through MAP kinase cascades Adv Cancer Res 74 1998 49 139 (Pubitemid 28193546)
30. M. Malumbres, and M. Barbacid RAS oncogenes: the first 30 years Nat Rev Cancer 3 2003 459 465 (Pubitemid 37328850)
31. M.M. McKay, and D.K. Morrison Integrating signals from RTKs to ERK/MAPK Oncogene 26 2007 3113 3121 (Pubitemid 46763008)
32. N. Thompson, and J. Lyons Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery Curr Opin Pharmacol 5 2005 350 356 (Pubitemid 40932036)
33. S.A. Moodie, and A. Wolfman The 3Rs of life: Ras, Raf and growth regulation Trends Genet 10 1994 44 48 (Pubitemid 24052926)
34. M.R. Lackner, K. Kornfeld, L.M. Miller, H.R. Horvitz, and S.K. Kim A MAP kinase homolog, mpk-1, is involved in ras-mediated induction of vulval cell fates in Caenorhabditis elegans Genes Dev 8 1994 160 173 (Pubitemid 24044340)
35. Y. Wu, M. Han, and K.L. Guan MEK-2, a Caenorhabditis elegans MAP kinase kinase, functions in Ras-mediated vulval induction and other developmental events Genes Dev 9 1995 742 755
36. G. Tzivion, Z. Luo, and J. Avruch A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity Nature 394 1998 88 92 (Pubitemid 28321808)
37. C. Finnie, J. Borch, and D.B. Collinge 14-3-3 proteins: eukaryotic regulatory proteins with many functions Plant Mol Biol 40 1999 545 554
38. H. Fu, R.R. Subramanian, and S.C. Masters 14-3-3 proteins: structure, function, and regulation Annu Rev Pharmacol Toxicol 40 2000 617 647 (Pubitemid 30340695)
39. S. Li, P. Janosch, and M. Tanji Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins EMBO J 14 1995 685 696
40. W.J. Fantl, A.J. Muslin, and A. Kikuchi Activation of Raf-1 by 14-3-3 proteins Nature 371 1994 612 614 (Pubitemid 24315743)
41. K. Irie, Y. Gotoh, and B.M. Yashar Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase Science 265 1994 1716 1719 (Pubitemid 24314904)
42. A.J. Muslin, J.W. Tanner, P.M. Allen, and A.S. Shaw Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine Cell 84 1996 889 897 (Pubitemid 26106858)
43. M. Therrien, H.C. Chang, and N.M. Solomon KSR, a novel protein kinase required for RAS signal transduction Cell 83 1995 879 888 (Pubitemid 26006530)
44. A. Claperon, and M. Therrien KSR and CNK: two scaffolds regulating RAS-mediated RAF activation Oncogene 26 2007 3143 3158 (Pubitemid 46763011)
45. A. Nguyen, W.R. Burack, and J.L. Stock Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo Mol Cell Biol 22 2002 3035 3045 (Pubitemid 34437462)
46. M.A. Farrar, Alberol-Ila, and R.M. Perlmutter Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization Nature 383 1996 178 181 (Pubitemid 26303982)
47. Z. Luo, G. Tzivion, and P.J. Belshaw Oligomerization activates c-Raf-1 through a Ras-dependent mechanism Nature 383 1996 181 185 (Pubitemid 26303983)
48. T. Rajakulendran, M. Sahmi, M. Lefrancois, F. Sicheri, and M. Therrien A dimerization-dependent mechanism drives RAF catalytic activation Nature 461 2009 542 545
49. D. Dworakowska, and A.B. Grossman The pathophysiology of pituitary adenomas Best Pract Res Clin Endocrinol Metab 23 2009 525 541
50. A.A. Adjei, and M. Hidalgo Intracellular signal transduction pathway proteins as targets for cancer therapy J Clin Oncol 23 2005 5386 5403 (Pubitemid 46206992)
51. I. Ewing, S. Pedder-Smith, and G. Franchi A mutation and expression analysis of the oncogene BRAF in pituitary adenomas Clin Endocrinol (Oxf) 66 2007 348 352 (Pubitemid 46239291)
52. I. De Martino, M. Fedele, and D. Palmieri B-RAF mutations are a rare event in pituitary adenomas J Endocrinol Invest 30 2007 RC1 RC3
53. Y. Lee, J.M. Kim, and E.J. Lee Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation J Endocrinol 199 2008 191 199
54. G. Vlotides, E. Siegel, and I. Donangelo Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands Cancer Res 68 2008 6377 6386
55. F.Y. Gong, Y.F. Shi, and J.Y. Deng The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells J Endocrinol 190 2006 397 406
56. A.G. Gilman G proteins: transducers of receptor-generated signals Annu Rev Biochem 56 1987 615 649
57. D. Cervantes, C. Crosby, and Y. Xiang Arrestin orchestrates crosstalk between G protein-coupled receptors to modulate the spatiotemporal activation of ERK MAPK Circ Res 106 2010 79 88
58. R.G.J. Della, S. Maudsley, Y. Daaka, R.J. Lefkowitz, and L.M. Luttrell Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases J Biol Chem 274 1999 13978 13984
59. A. Lania, M. Filopanti, and S. Corbetta Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells J Clin Endocrinol Metab 88 2003 1692 1696 (Pubitemid 36623390)
60. L.M. Luttrell, Y. Daaka, R.G.J. Della, and R.J. Lefkowitz G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases J Biol Chem 272 1997 31648 31656 (Pubitemid 28013311)
61. Z. Naor Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor Front Neuroendocrinol 30 2009 10 29
62. R. Wetzker, and F.D. Bohmer Transactivation joins multiple tracks to the ERK/MAPK cascade Nat Rev Mol Cell Biol 4 2003 651 657 (Pubitemid 36934967)
63. A. Lania, G. Mantovani, and A. Spada Genetics of pituitary tumors: focus on G-protein mutations Exp Biol Med (Maywood) 228 2003 1004 1017 (Pubitemid 37222168)
64. A. Lania, and A. Spada G-protein and signalling in pituitary tumours Horm Res 71 Suppl. 2 2009 95 100
65. A.G. Lania, G. Mantovani, and A. Spada Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases Nat Clin Pract Endocrinol Metab 2 2006 681 693 (Pubitemid 44901189)
66. G. Mantovani, and A. Spada Mutations in the Gs alpha gene causing hormone resistance Best Pract Res Clin Endocrinol Metab 20 2006 501 513 (Pubitemid 44872636)
67. N.A. Hibberts, D.J. Simpson, and J.E. Bicknell Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors Clin Cancer Res 5 1999 2133 2139 (Pubitemid 29399269)
68. S. Jordan, K. Lidhar, M. Korbonits, D.G. Lowe, and A.B. Grossman Cyclin D and cyclin E expression in normal and adenomatous pituitary Eur J Endocrinol 143 2000 R1 R6
69. T. Lei, E.F. Adams, M. Buchfelder, and R. Fahlbusch Relationship between protein kinase C and adenylyl cyclase activity in the regulation of growth hormone secretion by human pituitary somatotrophinomas Neurosurgery 39 1996 569 575 discussion 575-576
70. N. Reiss, L.N. Llevi, and S. Shacham Mechanism of mitogen-activated protein kinase activation by gonadotropin-releasing hormone in the pituitary of alphaT3-1 cell line: differential roles of calcium and protein kinase C Endocrinology 138 1997 1673 1682 (Pubitemid 27137121)
71. C. Tian, F. Ye, and T. Xu GHRP-6 induces CREB phosphorylation and growth hormone secretion via a protein kinase Csigma-dependent pathway in GH3 cells J Huazhong Univ Sci Technol Med Sci 30 2010 183 187
72. M. Fernandez, F. Sanchez-Franco, N. Palacios, I. Sanchez, and L. Cacicedo IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1 J Mol Endocrinol 34 2005 699 712 (Pubitemid 40903595)
73. D. Morimoto, D. Yoshida, and M. Noha Phosphorylation of cAMP response element binding protein (CREB) as a marker of hypoxia in pituitary adenoma J Neurooncol 79 2006 143 150 (Pubitemid 44349941)
74. A.D. Howard, S.D. Feighner, and D.F. Cully A receptor in pituitary and hypothalamus that functions in growth hormone release Science 273 1996 974 977 (Pubitemid 26275178)
75. M. Kojima, H. Hosoda, and Y. Date Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660 (Pubitemid 129516334)
76. M. Kojima, H. Hosoda, H. Matsuo, and K. Kangawa Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor Trends Endocrinol Metab 12 2001 118 122 (Pubitemid 33714199)
77. C. Dieguez, and F.F. Casanueva Ghrelin: a step forward in the understanding of somatotroph cell function and growth regulation Eur J Endocrinol 142 2000 413 417 (Pubitemid 30341170)
78. R.G. Smith, L.H. Van der Ploeg, and A.D. Howard Peptidomimetic regulation of growth hormone secretion Endocr Rev 18 1997 621 645 (Pubitemid 27435537)
79. K. Kim, K. Arai, and N. Sanno Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas Clin Endocrinol (Oxf) 54 2001 759 768 (Pubitemid 34208887)
80. K. Kim, N. Sanno, and K. Arai Ghrelin mRNA and GH secretagogue receptor mRNA in human GH-producing pituitary adenomas is affected by mutations in the alpha subunit of G protein Clin Endocrinol (Oxf) 59 2003 630 636 (Pubitemid 37357625)
81. T. Xu, F. Ye, and B. Wang Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation Neuro Endocrinol Lett 31 2010 147 154
82. E.F. Adams, B. Petersen, T. Lei, M. Buchfelder, and R. Fahlbusch The growth hormone secretagogue, L-692, 429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors Biochem Biophys Res Commun 208 1995 555 561
83. C. Chen Growth hormone secretagogue actions on the pituitary gland: multiple receptors for multiple ligands Clin Exp Pharmacol Physiol 27 2000 323 329 (Pubitemid 30313429)
84. T. Lei, M. Buchfelder, R. Fahlbusch, and E.F. Adams Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells J Mol Endocrinol 14 1995 135 138
85. J.P. Harwood, C. Grewe, and G. Aguilera Actions of growth hormone-releasing factor and somatostatin on adenylate cyclase and growth hormone release in rat anterior pituitary Mol Cell Endocrinol 37 1984 277 284 (Pubitemid 14031900)
86. J.S. Gutkind The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades J Biol Chem 273 1998 1839 1842 (Pubitemid 28069221)
87. D. Mousseaux, G.L. Le, and J. Ryan Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKC varepsilon pathway Br J Pharmacol 148 2006 350 365 (Pubitemid 43801182)
88. A.M. Nanzer, S. Khalaf, and A.M. Mozid Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway Eur J Endocrinol 151 2004 233 240 (Pubitemid 39207019)
89. W. Kolch, G. Heidecker, and G. Kochs Protein kinase C alpha activates RAF-1 by direct phosphorylation Nature 364 1993 249 252 (Pubitemid 23257085)
90. O. Sozeri, K. Vollmer, and M. Liyanage Activation of the c-Raf protein kinase by protein kinase C phosphorylation Oncogene 7 1992 2259 2262
91. D.A. Walsh, and S.M. Van Patten Multiple pathway signal transduction by the cAMP-dependent protein kinase FASEB J 8 1994 1227 1236
92. S.O. Doskeland, E. Maronde, and B.T. Gjertsen The genetic subtypes of cAMP-dependent protein kinase - functionally different or redundant Biochim Biophys Acta 1178 1993 249 258 (Pubitemid 23276217)
93. F.Y. Ma, D.R. Grattan, L. Bobrovskaya, P.R. Dunkley, and S.J. Bunn Angiotensin II regulates tyrosine hydroxylase activity and mRNA expression in rat mediobasal hypothalamic cultures: the role of specific protein kinases J Neurochem 90 2004 431 441 (Pubitemid 38938228)
94. G.S. McKnight Cyclic AMP second messenger systems Curr Opin Cell Biol 3 1991 213 217 (Pubitemid 121006089)
95. M.D. Uhler, D.F. Carmichael, and D.C. Lee Isolation of cDNA clones coding for the catalytic subunit of mouse cAMP-dependent protein kinase Proc Natl Acad Sci USA 83 1986 1300 1304 (Pubitemid 16016116)
96. J. Kawabe, G. Iwami, and T. Ebina Differential activation of adenylyl cyclase by protein kinase C isoenzymes J Biol Chem 269 1994 16554 16558 (Pubitemid 24200406)
97. A. Garcia, C.V. Alvarez, R.G. Smith, and C. Dieguez Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor Mol Endocrinol 15 2001 1484 1495 (Pubitemid 32826401)
98. M. Cerezo, M.L. Laorden, and M.V. Milanes Inhibition of protein kinase C but not protein kinase A attenuates morphine withdrawal excitation of rat hypothalamus-pituitary-adrenal axis Eur J Pharmacol 452 2002 57 66 (Pubitemid 35248124)
99. T. Hamid, M.T. Malik, R.P. Millar, and S.S. Kakar Protein kinase A serves as a primary pathway in activation of Nur77 expression by gonadotropin- releasing hormone in the LbetaT2 mouse pituitary gonadotroph tumor cell line Int J Oncol 33 2008 1055 1064
100. J. Vela, M.I. Perez-Millan, D. Becu-Villalobos, and G. Diaz-Torga Different kinases regulate activation of voltage-dependent calcium channels by depolarization in GH3 cells Am J Physiol Cell Physiol 293 2007 C951 959
101. J. Baselga Targeting tyrosine kinases in cancer: the second wave Science 312 2006 1175 1178 (Pubitemid 43801135)
102. I. Puzanov, P. Burnett, and K.T. Flaherty Biological challenges of BRAF inhibitor therapy Mol Oncol 5 2011 116 123
103. S.V. Sharma, and J. Settleman Oncogene addiction: setting the stage for molecularly targeted cancer therapy Genes Dev 21 2007 3214 3231 (Pubitemid 350277749)
104. A. Zebisch, A.P. Czernilofsky, and G. Keri Signaling through RAS-RAF-MEK-ERK: from basics to bedside Curr Med Chem 14 2007 601 623 (Pubitemid 46477731)
105. C. Rommel, B.A. Clarke, and S. Zimmermann Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt Science 286 1999 1738 1741 (Pubitemid 129515881)
106. A. Secondo, M. De Mizio, L. Zirpoli, M. Santillo, and P. Mondola The Cu-Zn superoxide dismutase (SOD1) inhibits ERK phosphorylation by muscarinic receptor modulation in rat pituitary GH3 cells Biochem Biophys Res Commun 376 2008 143 147
107. J.S. Sebolt-Leopold Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway Clin Cancer Res 14 2008 3651 3656
108. J. Zhang, P.L. Yang, and N.S. Gray Targeting cancer with small molecule kinase inhibitors Nat Rev Cancer 9 2009 28 39
109. K.E. Conrad, J.M. Oberwetter, R. Vaillancourt, G.L. Johnson, and A. Gutierrez-Hartmann Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression Mol Cell Biol 14 1994 1553 1565 (Pubitemid 24074551)
110. S.L. Fougner, J. Bollerslev, and F. Latif Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment J Clin Endocrinol Metab 93 2008 1211 1216 (Pubitemid 351519712)
111. A.M. Navratil, S.P. Bliss, and K.A. Berghorn Constitutive localization of the gonadotropin-releasing hormone (GnRH) receptor to low density membrane microdomains is necessary for GnRH signaling to ERK J Biol Chem 278 2003 31593 31602 (Pubitemid 37048337)
112. D. Romano, M. Pertuit, and R. Rasolonjanahary Regulation of the RAP1/RAF-1/extracellularly regulated kinase-1/2 cascade and prolactin release by the phosphoinositide 3-kinase/AKT pathway in pituitary cells Endocrinology 147 2006 6036 6045 (Pubitemid 44833523)
113. R.E. Schweppe, A.A. Frazer-Abel, A. Gutierrez-Hartmann, and A.P. Bradford Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. Identification of FGF response elements in the prolactin gene J Biol Chem 272 1997 30852 30859 (Pubitemid 27527527)
114. D.N. Dhanasekaran, K. Kashef, C.M. Lee, H. Xu, and E.P. Reddy Scaffold proteins of MAP-kinase modules Oncogene 26 2007 3185 3202 (Pubitemid 46763014)
115. W. Kolch Coordinating ERK/MAPK signalling through scaffolds and inhibitors Nat Rev Mol Cell Biol 6 2005 827 837 (Pubitemid 41568732)
116. S.M. Stoeger, and K.H. Cowan Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines Cancer Chemother Pharmacol 63 2009 807 818
117. W. Cao, X. Yang, and J. Zhou Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice Apoptosis 15 2010 230 241
118. X. Yang, W. Cao, and J. Zhou 14-3-3zeta positive expression is associated with a poor prognosis in patients with glioblastoma Neurosurgery 68 2011 932 938
119. E. Hubina, A.M. Nanzer, and M.R. Hanson Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours Eur J Endocrinol 155 2006 371 379 (Pubitemid 44269455)